Name | Title | Contact Details |
---|---|---|
Eron Davis |
Global Talent Director | Profile |
John Leite |
Chief Commercial Officer, CLIA | Profile |
Jonathan Wygant |
Chief Accounting Officer | Profile |
Samantha Gooden |
Associate Director, Laboratory Operations - Richmond | Profile |
Jeff Ning |
Director, R&D Infrastructure | Profile |
Arch Oncology, Inc. is a clinical-stage immuno-oncology company focused on the discovery and development of potential best-in-class antibody therapies for the treatment of patients with solid tumors and hematologic malignancies.
BIOAGE has a diverse team of computational biologists and medical scientists with expertise in aging and translational research. We share the vision that a synergy of machine learning approaches, high throughput human omics data, and new experimental approaches will make it possible to discover therapies that address unmet medical needs in an aging population.
IMS Group is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Altea Therapeutics Corporation is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Trait Biosciences Inc. is a leading biotechnology research organization providing proprietary technology to enable safer, lower cost, predictable, and superior quality cannabinoid products. With a world-class team of scientists and PhDs from more than 20 countries collaborating in our state-of-the-art Los Alamos laboratory, Trait Biosciences researchers are unlocking new breakthroughs in cannabinoid science. Trait Biosciences offers transformative technologies that create water-soluble cannabinoids, increase cannabinoid production, protect the plants from disease, tailor the production of cannabinoids and that can assure zero THC for hemp.